Found: 12
Select item for more details and to access through your institution.
Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138389
- By:
- Publication type:
- Article
Management of adrenocortical carcinoma: are we making progress?
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211038409
- By:
- Publication type:
- Article
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3692, doi. 10.3390/curroncol28050315
- By:
- Publication type:
- Article
Management of adrenocortical carcinoma: are we making progress?
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211038409
- By:
- Publication type:
- Article
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1650, doi. 10.1007/s00259-020-05082-5
- By:
- Publication type:
- Article
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 713, doi. 10.1007/s00259-019-04584-1
- By:
- Publication type:
- Article
Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors – Experiences from a tertiary referral center.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 8, p. 1, doi. 10.1111/jne.13319
- By:
- Publication type:
- Article
Response and Toxicity to the Second Course of 3 Cycles of 177 Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2489, doi. 10.3390/cancers13102489
- By:
- Publication type:
- Article
In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR).
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3446, doi. 10.3390/jcm9113446
- By:
- Publication type:
- Article
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241240316
- By:
- Publication type:
- Article
Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters.
- Published in:
- Journal of Nuclear Cardiology, 2023, v. 30, n. 4, p. 1363, doi. 10.1007/s12350-022-03149-4
- By:
- Publication type:
- Article
Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
- Published in:
- Journal of Nuclear Cardiology, 2023, v. 30, n. 1, p. 357, doi. 10.1007/s12350-022-02986-7
- By:
- Publication type:
- Article